http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 27 Feb 2026 06:47:39 +0000 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Arcutis+Biotherapeutics+%28AQRT%29+PT+Raised+to+%2435+at+Guggenheim/26075381.html Guggenheim analyst Seamus Fernandez raised the price target on Arcutis Biotherapeutics (: AQRT) to $35.00 (from $34.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Arcutis+Biotherapeutics+%28AQRT%29+PT+Raised+to+%2435+at+Guggenheim/26075381.html Fri, 27 Feb 2026 06:47:39 +0000 AQRT http://www.streetinsider.com/Analyst+PT+Change/Arcutis+Biotherapeutics+%28AQRT%29+PT+Raised+to+%2455+at+Stifel/25575463.html Stifel raised its price target on Arcutis Biotherapeutics (: AQRT) to $55.00 (from $46.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Arcutis+Biotherapeutics+%28AQRT%29+PT+Raised+to+%2455+at+Stifel/25575463.html Fri, 07 Nov 2025 08:08:17 +0000 AQRT http://www.streetinsider.com/Analyst+PT+Change/Arcutis+Biotherapeutics+%28AQRT%29+PT+Raised+to+%2421+at+Morgan+Stanley/25163557.html Morgan Stanley raised its price target on Arcutis Biotherapeutics (: AQRT) to $21.00 (from $20.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Arcutis+Biotherapeutics+%28AQRT%29+PT+Raised+to+%2421+at+Morgan+Stanley/25163557.html Thu, 07 Aug 2025 08:20:51 +0000 AQRT